attenuated some responses, permeability endpoint not clearly met
Table of Contents What Cagrilintide and Retatrutide Are and How They Work Approved Uses and Current Clinical Evidence in the UK How These Medicines May Affect Men Specifically Dosage, Administration, and What to Expect Side Effects, Risks, and Safety Considerations Availability on the NHS and Next Steps for Treatment Scientific References Frequently Asked Questions What Cagrilintide and Retatrutide Are and How They Work Cagrilintide is a long-acting amylin analogue that promotes satiety and slows gastric emptying, while retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite, enhance insulin secretion, and increase energy expenditure
Its less about managing the symptoms of aging and more about addressing the process at a cellular level
Immediate post-injection care focuses on minimising local reactions: Apply a cold compress to the injection site for 1015 minutes to reduce pain and swelling Avoid massaging or rubbing the area, which can increase bruising Wear loose clothing that doesn't irritate the injection site Gentle movement of the affected limb may help reduce stiffness Hydration and nutrition support general wellbeing during treatment
Cartilage and chondrocyte research that emerged after the obesity program ended, exploring AOD-9604's effects on osteoarthritis-relevant pathways in cartilage explants and synovial tissue models